Peter Anastasiou
Fortuna: - $ al 30/09/2026
Fortuna: - $ al 30/09/2026
Mr. Peter E.
Anastasiou is a Chief Operating Officer & Senior EVP at Harmony Biosciences Holdings, Inc. He is on the Board of Directors at Pharmaceutical Research & Manufacturers of America.
Mr. Anastasiou was previously employed as a Chief Executive Officer & Director by Capsida Biotherapeutics, Inc., an Executive Vice President-North America by H.
Lundbeck A/S, a Vice President-Marketing by Neuronetics, Inc., a Marketing Director by Bristol Myers Squibb Co., a Principal by Eli Lilly & Co., and a President by Lundbeck Seattle BioPharmaceuticals, Inc. He received his undergraduate degree from Albion College and an MBA from Kelley School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/04/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director de Operaciones | 02/04/2026 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Miembro de la Junta | 01/07/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Director Ejecutivo | 01/10/2025 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 31/12/2021 |
| ALDER BIOPHARMACEUTICALS, INC. | Presidente | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Neuronetics, Inc.
Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Albion College
Albion College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.